{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T14:23:01Z","timestamp":1695910981808},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1007\/bf02244879","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T05:10:08Z","timestamp":1132031408000},"page":"103-109","source":"Crossref","is-referenced-by-count":7,"title":["Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats"],"prefix":"10.1007","volume":"116","author":[{"given":"R. Christopher","family":"Pierce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy J.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George V.","family":"Rebec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02244879_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0301-0082(90)90014-8","volume":"35","author":"RN Adams","year":"1990","unstructured":"Adams RN (1990) In vivo electrochemical measurements in the CNS. Prog Neurobiol 35:297\u2013311","journal-title":"Prog Neurobiol"},{"key":"BF02244879_CR2","volume-title":"Handbook of Psychopharmacology, Vol. 15","author":"RN Adams","year":"1982","unstructured":"Adams RN, Marsden CA (1982) Electrochemical detection methods for monamine measurement in vitro and in vivo. In: Iverson LL, Iverson SD, Snyder SH (eds) Handbook of Psychopharmacology, Vol. 15. Plenum Press, New York"},{"key":"BF02244879_CR3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0091-3057(90)90204-U","volume":"35","author":"A Basse-Tomusk","year":"1990","unstructured":"Basse-Tomusk A, Rebec GV (1990) Coricostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Pharmacol Biochem Behav 35:55\u201360","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244879_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-8993(91)90372-3","volume":"538","author":"A Basse-Tomusk","year":"1991","unstructured":"Basse-Tomusk A, Rebec GV (1991) Regional distribution of ascorbate and, 3,4-dihydroxyphenylacetic acid (DOPAC) in rat neostriatum. Brain Res 538:29\u201335","journal-title":"Brain Res"},{"key":"BF02244879_CR5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00004714-198708000-00037","volume":"7","author":"L Beauclair","year":"1987","unstructured":"Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE (1987) An adjunctive role for ascorbic acid in the treatment of schizophrenia? J Clin Psychopharmacol 7:282\u2013283","journal-title":"J Clin Psychopharmacol"},{"key":"BF02244879_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002826-198306000-00008","volume":"6","author":"RL Borison","year":"1983","unstructured":"Borison RL, Hitri A, Blowers AJ, Diamond BI (1983) Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of action. Clin Neuropharmacol 6:137\u2013150","journal-title":"Clin Neuropharmacol"},{"key":"BF02244879_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0006-8993(91)91731-F","volume":"565","author":"J Cammack","year":"1991","unstructured":"Cammack J, Ghasemzedeh B, Adams RN (1991) The pharmacological profile of glutamate-induced ascorbic acid efflux measured by in vivo electrochemistry. Brain Res 565:17\u201322","journal-title":"Brain Res"},{"key":"BF02244879_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","volume":"1","author":"A Carlsson","year":"1988","unstructured":"Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179\u2013186","journal-title":"Neuropsychopharmacology"},{"key":"BF02244879_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","volume":"13","author":"M Carlsson","year":"1990","unstructured":"Carlsson M, Carlsson A (1990) Interactions between glutaminergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272\u2013276","journal-title":"Trends Neurosci"},{"key":"BF02244879_CR10","first-page":"327","volume":"77","author":"R Cespuglio","year":"1981","unstructured":"Cespuglio R, Faradji H, Ponchon J-L, Riou F, Buda M, Gonon F, Pujol J-F, Jouvet M (1981) In vivo measurement by differential pulse voltammetry of extracellular 5-hydroxyindoleacetic acid in the rat brain. J Physiol (Paris) 77:327\u2013332","journal-title":"J Physiol"},{"key":"BF02244879_CR11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","volume":"1","author":"DW Choi","year":"1988","unstructured":"Choi DW (1988) Glutamate neurotoxicity and disease of the nervous system. Neuron 1:623\u2013634","journal-title":"Neuron"},{"key":"BF02244879_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/S0007125000296840","volume":"160","author":"DM Coward","year":"1992","unstructured":"Coward DM (1992) General pharmacology of clozapine. Br J Psychiatry 160:5\u201311","journal-title":"Br J Psychiatry"},{"key":"BF02244879_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(84)91192-2","volume":"332","author":"F Crespi","year":"1984","unstructured":"Crespi F, Sharp T, Maidement NT, Marsden CA (1984) Differential pulse voltammetry: simultaneous in vivo measurement of ascorbic acid, catechols and 5-hydroxyindoles in the rat striatum. Brain Res 332:135\u2013138","journal-title":"Brain Res"},{"key":"BF02244879_CR14","first-page":"495","volume":"24","author":"TJ Crow","year":"1980","unstructured":"Crow TJ, Cross AJ, Johnstone EC, Longden A, Owen F, Ridley RM (1980) Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication. Adv Biochem Psychopharmacol 24:495\u2013503","journal-title":"Adv Biochem Psychopharmacol"},{"key":"BF02244879_CR15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(92)90581-N","volume":"219","author":"MS Desole","year":"1992","unstructured":"Desole MS, Miele M, Enrico P, Esposito G, Fresu L, Denatale G, Miele E (1992) Effects of cortical ablation on apomorphine-induced and scopolamine-induced changes in dopamine turnover and ascorbic acid catabolism in the rat striatum. Eur J Pharmacol 219:67\u201374","journal-title":"Eur J Pharmacol"},{"key":"BF02244879_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0920-9964(91)90030-U","volume":"4","author":"AY Deutch","year":"1991","unstructured":"Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS, Charney DS (1991) Mechnisms of action of atypical antipsychotic drugs: implications for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121\u2013156","journal-title":"Schizophr Res"},{"key":"BF02244879_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3181\/00379727-186-42576","volume":"186","author":"RL Dorris","year":"1987","unstructured":"Dorris RL (1987) Ascorbic acid reduces the accumulation of [3H]spiperone in mouse striatum in vivo. Proc Soc Exp Biol Med 186:13\u201316","journal-title":"Proc Soc Exp Biol Med"},{"key":"BF02244879_CR18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0091-3057(86)90592-7","volume":"24","author":"RL Dorris","year":"1986","unstructured":"Dorris RL, Dill RE (1986) Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates. Pharamcol Biochem Behav 24:781\u2013783","journal-title":"Pharamcol Biochem Behav"},{"key":"BF02244879_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0006-8993(82)90070-1","volume":"249","author":"AG Ewing","year":"1982","unstructured":"Ewing AG, Wightman RM, Dayton MA (1982) In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate. Brain Res 249:361\u2013370","journal-title":"Brain Res"},{"key":"BF02244879_CR20","first-page":"144","volume-title":"Monitoring neurotransmitter release during behaviour","author":"M Fillenz","year":"1986","unstructured":"Fillenz M. O'Neill RD, Grunewald RA (1986) Changes in extracellular brain ascorbate concentration as an index of excitatory aminoacid release. In: Joseph MH, Fillenz M, MacDonald IA, Marsden CA (eds) Monitoring neurotransmitter release during behaviour. Ellis Horwood, Chichester, pp 144\u2013163"},{"key":"BF02244879_CR21","first-page":"162","volume":"547","author":"B Ghasemzedeh","year":"1991","unstructured":"Ghasemzedeh B, Cammack J Adams RN (1991) Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry. Brain Res 547:162\u2013166","journal-title":"Brain Res"},{"key":"BF02244879_CR22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.144.9.1207","volume":"144","author":"AJ Giannini","year":"1987","unstructured":"Giannini AJ, Loiselle RH, DiMarzio LR, Giannini MC (1987) Augmentation of haloperidol by ascorbic acid in phencyclidine intoxication. Am J Psychiatry 144:1207\u20131209","journal-title":"Am J Psychiatry"},{"key":"BF02244879_CR23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/286902a0","volume":"286","author":"F Gonon","year":"1980","unstructured":"Gonon F, Buda M, Cespuglio R, Jouvet M, Pujol F (1980) In vivo electrochemical detection of catechols in the neostriatum of anaesthetized rats: dopamine or DOPAC? Nature 286:902\u2013904","journal-title":"Nature"},{"key":"BF02244879_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(81)90807-6","volume":"223","author":"F Gonon","year":"1981","unstructured":"Gonon F, Buda M, Cespuglio R, Jouvet M, Pujol JF (1981) Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid. Brain Res 223:69\u201380","journal-title":"Brain Res"},{"key":"BF02244879_CR25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1021\/ac00267a060","volume":"56","author":"FG Gonon","year":"1984","unstructured":"Gonon FG, Navarro F, Buda MJ (1984) In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry. Anal Chem 56:573\u2013575","journal-title":"Anal Chem"},{"key":"BF02244879_CR26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/archneur.1986.00520100062016","volume":"43","author":"JT Greenamyre","year":"1986","unstructured":"Greenamyre JT (1986) The role of glutamate in neurotransmission and neurologic disease. Arch Neurol 43:1058\u20131063","journal-title":"Arch Neurol"},{"key":"BF02244879_CR27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-0173(93)90010-W","volume":"18","author":"RA Grunewald","year":"1993","unstructured":"Grunewald RA (1993) Ascorbic acid in the brain. Brain Res Rev 18:123\u2013133","journal-title":"Brain Res Rev"},{"key":"BF02244879_CR28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0028-3908(83)90209-5","volume":"22","author":"M Hadjiconstantinou","year":"1983","unstructured":"Hadjiconstantinou M, Neff NH (1983) Ascorbic acid could be hazardous to your experiment: a commentary on dopamine receptor binding studies with speculation on a role for ascorbic acid in neuronal function. Neuropharmacology 22:939\u2013943","journal-title":"Neuropharmacology"},{"key":"BF02244879_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0028-3908(83)90274-5","volume":"22","author":"RE Heikkila","year":"1983","unstructured":"Heikkila RE, Manzino L, Cabbat FS, Hanly JG (1983) Ascorbic acid and the binding of DA agonists to neostriatal membrane preparations. Neuropharmacology 22:135\u2013137","journal-title":"Neuropharmacology"},{"key":"BF02244879_CR30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0361-9230(89)90097-X","volume":"22","author":"L Hernandez","year":"1989","unstructured":"Hernandez L, Hoebel BG (1989) Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Brain Res Bull 22:763\u2013769","journal-title":"Brain Res Bull"},{"key":"BF02244879_CR31","first-page":"348","volume":"256","author":"J Ichikawa","year":"1991","unstructured":"Ichikawa J, Meltzer H (1991) Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. J Pharmacol Exp Ther 256:348\u2013357","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02244879_CR32","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","volume":"i","author":"EC Johnstone","year":"1978","unstructured":"Johnstone EC, Crow TJ, Frith CD, Carney MWP, Price JS (1978) Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet i:848\u2013851","journal-title":"Lancet"},{"key":"BF02244879_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/0896031039","volume-title":"Voltammetry in the neurosciences, principles, methods, and applications","author":"JB Justice","year":"1987","unstructured":"Justice JB (1987) Introduction to in vivo voltammetry. In: Justice Jr JB (ed) Voltammetry in the neurosciences, principles, methods, and applications. Humana Press, Clifton, New Jersey, pp 3\u2013101"},{"key":"BF02244879_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(86)90458-0","volume":"362","author":"K Kamata","year":"1986","unstructured":"Kamata K, Wilson RL, Alloway KD, Rebec GV (1986) Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat. Brain Res 362:331\u2013338","journal-title":"Brain Res"},{"key":"BF02244879_CR35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1385\/0-89603-122-5:261","volume-title":"Neuromethods, vol 12: drugs as tools in neurotransmitter research","author":"PM Laduron","year":"1989","unstructured":"Laduron PM (1989) Dopamine receptors and neuroleptics drugs. In: Boulton AB, Baker GB, Juorio AV (eds) Neuromethods, vol 12: drugs as tools in neurotransmitter research. Humana Press, Clifton, New Jersey, pp 261\u2013298"},{"key":"BF02244879_CR36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1471-4159.1980.tb04645.x","volume":"34","author":"FM Leslie","year":"1980","unstructured":"Leslie FM, Dunlap III CE, Cox BM (1980) Ascorbate decreases ligand binding to neurotransmitter receptors. J Neurochem 34:219\u2013221","journal-title":"J Neurochem"},{"key":"BF02244879_CR37","first-page":"103","volume-title":"A new generation of antipsychotic drugs: novel mechanisms of action","author":"HY Meltzer","year":"1993","unstructured":"Meltzer HY (1993) Utilization, multidimensional outcome measures, and risk-benefit considerations for the use of clozapine in schizophrenia. In: Brunello N, Mendlewicz J, Racagni G (eds) A new generation of antipsychotic drugs: novel mechanisms of action. Int. Acad. Biomed. Drug Res. Karger, Basel, vol 14, pp 103\u2013117"},{"key":"BF02244879_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0304-3940(82)90201-4","volume":"28","author":"K Milby","year":"1982","unstructured":"Milby K, Oke A, Adams RN (1982) Detailed mapping of ascorbate distribution in rat brain. Neurosci Lett 28:15\u201320","journal-title":"Neurosci Lett"},{"key":"BF02244879_CR39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0006-8993(89)90140-6","volume":"494","author":"K Mueller","year":"1989","unstructured":"Mueller K (1989) Repeated administration of high doses of amphetamine increases release of ascorbic acid in caudate but not nucleus accumbens. Brain Res 494:30\u201335","journal-title":"Brain Res"},{"key":"BF02244879_CR40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00428036","volume":"59","author":"EB Neilsen","year":"1978","unstructured":"Neilsen EB, Lyon M (1978) Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenthixol) in rats. Psychopharmacology 59:85\u201389","journal-title":"Psychopharmacology"},{"key":"BF02244879_CR41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(89)91581-3","volume":"480","author":"C Oh","year":"1989","unstructured":"Oh C, Gardiner TW, Rebec GV (1989) Blockade of both D1-and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in neostriatum. Brain Res 480:184\u2013189","journal-title":"Brain Res"},{"key":"BF02244879_CR42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3940(82)90174-4","volume":"34","author":"RD O'Neill","year":"1982","unstructured":"O'Neill RD, Fillenz M, Albery WJ (1982) Circadian changes in homovanillic acid and ascorbate levels in the rat striatum using microprocessor-controlled voltammetry. Neurosci Lett 34:189\u2013193","journal-title":"Neurosci Lett"},{"key":"BF02244879_CR43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0304-3940(84)90166-6","volume":"42","author":"RD O'Neill","year":"1984","unstructured":"O'Neill RD, Fillenz M, Sundstrom L, Rawlins NP (1984) Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat. Neurosci Lett 42:227\u2013233","journal-title":"Neurosci Lett"},{"key":"BF02244879_CR44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00429280","volume":"29","author":"H Pakkenberg","year":"1973","unstructured":"Pakkenberg H, Fog R, Nilakantan B (1973) The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomica; findings. Psychopharmacologia 29:329\u2013336","journal-title":"Psychopharmacologia"},{"key":"BF02244879_CR45","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1982","unstructured":"Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York"},{"key":"BF02244879_CR46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(90)94161-P","volume":"191","author":"RC Pierce","year":"1990","unstructured":"Pierce RC, Rebec GV (1990) Stimulation of both D1 and D2 receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats. Eur J Pharmacol 191:295\u2013302","journal-title":"Eur J Pharmacol"},{"key":"BF02244879_CR47","first-page":"94","volume":"10","author":"RC Pierce","year":"1991","unstructured":"Pierce RC, Rebec GV (1991) In vivo voltammetry in freely moving rats: effects of dopamine agonists and neuroleptics on neostriatal ascorbate. Curr Sep 10:94\u201395","journal-title":"Curr Sep"},{"key":"BF02244879_CR48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-8993(92)90741-Q","volume":"579","author":"RC Pierce","year":"1992","unstructured":"Pierce RC, Rebec GV (1992) Dopamine-, NMDA-, and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats. Brain Res 579:59\u201366","journal-title":"Brain Res"},{"key":"BF02244879_CR49","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1523\/JNEUROSCI.13-10-04272.1993","volume":"13","author":"RC Pierce","year":"1993","unstructured":"Pierce RC, Rebec (1993) Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via non-dopaminergic mechanisms. J Neurosci 13:4272\u20134280","journal-title":"J Neurosci"},{"key":"BF02244879_CR50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0306-4522(91)90234-F","volume":"45","author":"RC Pierce","year":"1991","unstructured":"Pierce RC, Rowlett JK, Bardo MT, Rebec GV (1991) Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding Neuroscience 45:373\u2013378","journal-title":"Neuroscience"},{"key":"BF02244879_CR51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0006-8993(92)91515-G","volume":"597","author":"RC Pierce","year":"1992","unstructured":"Pierce RC, Miller DM, Reising D, Rebec GV (1992) Unilateral neostriatal kainate, but not 6-OHDA lesions, block dopamine agonist-induced ascorbate release in the neostriatum of freely-moving rats. Bran Res 597:138\u2013143","journal-title":"Bran Res"},{"key":"BF02244879_CR52","first-page":"93","volume-title":"Biochemistry and physiology of substance abuse, vol. III","author":"GV Rebec","year":"1991","unstructured":"Rebec GV (1991) Changes in brain and behavior produced by amphetamine: a perspective based on microdialysis, voltammetry, and single-unit electrophysiology in freely moving animals. In: Watson RR (ed) Biochemistry and physiology of substance abuse, vol. III, CRC Press, Boca Raton, FL, pp 93\u2013115"},{"key":"BF02244879_CR53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0149-7634(84)90030-7","volume":"8","author":"GV Rebec","year":"1984","unstructured":"Rebec GV, Bashore TR (1984) Critical issues in assessing the behavioral effects of amphetamine. Neurosci Biobehav Rev 8:153\u2013159","journal-title":"Neurosci Biobehav Rev"},{"key":"BF02244879_CR54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00432771","volume":"77","author":"GV Rebec","year":"1982","unstructured":"Rebec GV, Peirson EE, McPherson FA, Brugge K (1982) Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol. Psychopharmacology 77:360\u2013366","journal-title":"Psychopharmacology"},{"key":"BF02244879_CR55","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.4038426","volume":"227","author":"GV Rebec","year":"1985","unstructured":"Rebec GV, Centore JC, White LK, Alloway KD (1985) Ascorbic acid and the behavioral response to haloperidol: implications for the action of antipsychotic drugs. Science 227:438\u2013440","journal-title":"Science"},{"key":"BF02244879_CR56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0165-0270(93)90021-I","volume":"47","author":"GV Rebec","year":"1993","unstructured":"Rebec GV, Langley PE, Pierce RC, Wang Z, Heidenreich BA (1993) A simple micromanipulator for multiple uses in freely moving rats: electrophysiology, voltammetry, and simultaneous intracerebral infusions. J Neurosci Methods 47:53\u201359","journal-title":"J Neurosci Methods"},{"key":"BF02244879_CR57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1192\/bjp.155.3.305","volume":"155","author":"GP Reynolds","year":"1989","unstructured":"Reynolds GP (1989) Beyond the dopamine hypothesis: the neurochemical pathology of schizophrenia. Br J Psychiatry 155:305\u2013316","journal-title":"Br J Psychiatry"},{"key":"BF02244879_CR58","first-page":"301","volume-title":"Stimultants: neurochemical, behavioral, and clinical perspectives","author":"TW Robbins","year":"1983","unstructured":"Robbins TW, Sahakian BJ (1983) Behavioral effects of psychomotor stimultant drugs: clinical and neuropsychological implications. In: Creese I (ed) Stimultants: neurochemical, behavioral, and clinical perspectives. Raven Press, New York, pp 301\u2013338"},{"key":"BF02244879_CR59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-2236(87)90177-9","volume":"10","author":"SM Rothman","year":"1987","unstructured":"Rothman SM, Olney JW (1987) Excitotoxicity and the NMDA receptor. Trends Neurosci 10:299\u2013302","journal-title":"Trends Neurosci"},{"key":"BF02244879_CR60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0006-8993(82)90709-0","volume":"253","author":"JO Schenk","year":"1982","unstructured":"Schenk JO, Miller E, Gaddis R, Adams RN (1982) Homeostatic control of ascorbate concentration in CNS extracellular fluid. Brain Res 253:353\u2013356","journal-title":"Brain Res"},{"key":"BF02244879_CR61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0024-3205(84)90148-6","volume":"35","author":"R Schwarcz","year":"1984","unstructured":"Schwarcz R, Foster AC, French ED, Whetsell WO, Kohler C (1984) Excitotoxic models for neurodegenerative disorders. Life Sci 35:19\u201332","journal-title":"Life Sci"},{"key":"BF02244879_CR62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0304-3940(92)90629-L","volume":"142","author":"RE See","year":"1992","unstructured":"See RE, Murray CE (1992) Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats. Neurosci Lett 142:100\u2013104","journal-title":"Neurosci Lett"},{"key":"BF02244879_CR63","first-page":"261","volume":"7","author":"P Seeman","year":"1992","unstructured":"Seeman P (1992) Dopamine receptor sequence: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261\u2013284","journal-title":"Neuropsychopharmacology"},{"key":"BF02244879_CR64","first-page":"1113","volume-title":"Psychopharmacology: a generation of progress","author":"DS Segal","year":"1978","unstructured":"Segal DS, Janowsky DS (1978) Psychostimultant-induced behavioral effects: possible models of schizophrenia. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1113\u20131123"},{"key":"BF02244879_CR65","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","volume":"33","author":"LS Seiden","year":"1993","unstructured":"Seiden LS, Sabol KE, Ricaurte, GA (1993) Amphetamine-effects on catecholamine systems and behavior. Annu rev Pharmacol Toxicol 33:639\u2013677","journal-title":"Annu rev Pharmacol Toxicol"},{"key":"BF02244879_CR66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/ajp.133.2.197","volume":"133","author":"SH Snyder","year":"1976","unstructured":"Snyder SH (1976) The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry 133:197\u2013202","journal-title":"Am J Psychiatry"},{"key":"BF02244879_CR67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004714-198904000-00011","volume":"9","author":"GM Straw","year":"1989","unstructured":"Straw GM, Bigelow LB, Kirch DG (1989) Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid. J Clin Psychopharmacol 9:130\u2013132","journal-title":"J Clin Psychopharmacol"},{"key":"BF02244879_CR68","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.me.35.020184.003133","volume":"35","author":"D Tarsey","year":"1984","unstructured":"Tarsey D, Baldessarini RJ (1984) Tardive dyskinesia. Annu Rev Med 35:605\u2013623","journal-title":"Annu Rev Med"},{"key":"BF02244879_CR69","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0024-3205(92)90400-J","volume":"51","author":"LC Tolbert","year":"1992","unstructured":"Tolbert LC, Morris PE, Spollen JJ, Ashe SC (1992) Stereospecific effects of ascorbic acid and analogues on D2 and D2 agonist binding. Life Sci 51:921\u2013930","journal-title":"Life Sci"},{"key":"BF02244879_CR70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hup.470020104","volume":"2","author":"JL Waddington","year":"1987","unstructured":"Waddington JL (1987) Tardive dyskinesia in schizophrenia and other disorders: associations with ageing cognitive dysfunction and structural brain pathology in relation to neuroleptic exposure. Hum Pyschopharmacol 2:11\u201322","journal-title":"Hum Pyschopharmacol"},{"key":"BF02244879_CR71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3940(89)90289-9","volume":"99","author":"BHC Westerink","year":"1989","unstructured":"Westerink BHC, DeVries JB (1989) On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99:197\u2013202","journal-title":"Neurosci Lett"},{"key":"BF02244879_CR72","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00176860","volume":"94","author":"LK White","year":"1988","unstructured":"White LK, Carpenter M, Block M, Basse-Tomusk A, Gardiner TW, Rebec GV (1988) Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism. Psychopharmacology 94:284\u2013287","journal-title":"Psychopharmacology"},{"key":"BF02244879_CR73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0091-3057(90)90245-D","volume":"36","author":"LK White","year":"1990","unstructured":"White LK, Maurer M, Sidell EA, Kraft ME, Oh C, Rebec GV (1990) Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine. Pharmacol Biochem Behav 36:485\u2013489","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244879_CR74","first-page":"103","volume-title":"Voltammetry in the neurosciences","author":"RM Wightman","year":"1987","unstructured":"Wightman RM, Brown DS, Kuhr WG, Wilson RL (1987) Molecular specificity of in vivo electrochemical measurements. In: J Justice Jr (ed) Voltammetry in the neurosciences. Humana Press, Clifton, NJ, pp 103\u2013138"},{"key":"BF02244879_CR75","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0024-3205(91)90136-Y","volume":"49","author":"SE Yount","year":"1991","unstructured":"Yount SE, Kraft ME, Pierce RC, Langley PE, Rebec GV (1991) Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats. Life Sci 49:1237\u20131244","journal-title":"Life Sci"},{"key":"BF02244879_CR76","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1460-9568.1991.tb00029.x","volume":"3","author":"T Zetterstrom","year":"1991","unstructured":"Zetterstrom T, Wheeler DB, Doutelle MG, Fillenz M (1991) Striatal ascorbate and its relationship to dopamine receptor stimulation and motor activity. Eur J Neurosci 3:940\u2013946","journal-title":"Eur J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02244879\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T23:32:09Z","timestamp":1557876729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02244879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["BF02244879"],"URL":"https:\/\/doi.org\/10.1007\/bf02244879","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}